KLK3 and prostate carcinoma: These results showed that 5-hydroxymethyl-2-furoic acid, ethylmalonic acid, and pyroglutamic acid could be used as biomarkers to differentiate prostate cancer with PSA < 4.0 ng/mL from that with PSA > 4.0 ng/mL.